C

Cannara Biotech Inc
XTSX:LOVE

Watchlist Manager
Cannara Biotech Inc
XTSX:LOVE
Watchlist
Price: 1.75 CAD 2.94%
Market Cap: 166.1m CAD

Operating Margin
Cannara Biotech Inc

-7.3%
Current
-16%
Average
6.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-7.3%
=
Operating Profit
-7.8m
/
Revenue
107.3m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CA
Cannara Biotech Inc
XTSX:LOVE
160m CAD
-7%
US
Eli Lilly and Co
NYSE:LLY
964.4B USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
506.7B USD
27%
CH
Roche Holding AG
SIX:ROG
251.6B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
208.2B GBP
24%
CH
Novartis AG
SIX:NOVN
202.9B CHF
33%
US
Merck & Co Inc
NYSE:MRK
247.6B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
209B USD
11%
US
Pfizer Inc
NYSE:PFE
146.6B USD
29%
No Stocks Found

Cannara Biotech Inc
Glance View

Market Cap
160m CAD
Industry
Pharmaceuticals

Cannara Biotech, Inc. is a pharmaceutical company, which operates cannabis biotech facility. The company is headquartered in Montreal, Quebec. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. Its segments include Indoor cannabis operations and Real estate operations. The Indoor cannabis operations segment includes the cultivation, processing and sale of dried cannabis and cannabis derivatives exclusively for the Quebec and Canadian market. The Real estate operations segment is related to the Farnham building. The Company, through ShopCBD.com Inc., operates an online e-commerce platform in the United States hemp-based Cannabidiol (CBD) market. The firm sells dried cannabis products to provincial retail distributors and other licensed producers across Canada through Cannara Biotech (Quebec) Inc. The company owns approximately two cultivation facilities based in Quebec spanning over 1,650,000 square feet.

LOVE Intrinsic Value
2.74 CAD
Undervaluation 36%
Intrinsic Value
Price
C
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-7.3%
=
Operating Profit
-7.8m
/
Revenue
107.3m
What is the Operating Margin of Cannara Biotech Inc?

Based on Cannara Biotech Inc's most recent financial statements, the company has Operating Margin of -7.3%.

Back to Top